1. GPCR/G Protein Neuronal Signaling Metabolic Enzyme/Protease
  2. 5-HT Receptor COMT Endogenous Metabolite
  3. Serotonin

Serotonin  (Synonyms: 5-Hydroxytryptamine; 5-HT)

Cat. No.: HY-B1473A Purity: 98.96%
Handling Instructions Technical Support

Serotonin is a monoamine neurotransmitter in the CNS and an endogenous 5-HT receptor agonist. Serotonin is also a catechol O-methyltransferase (COMT) inhibitor with a Ki of 44 μM.

For research use only. We do not sell to patients.

CAS No. : 50-67-9

Size Price Stock Quantity
Solid + Solvent (Highly Recommended)
10 mM * 1 mL in DMSO
ready for reconstitution
In-stock
Solution
10 mM * 1 mL in DMSO In-stock
Solid
1 mg In-stock
5 mg In-stock
10 mg In-stock
25 mg In-stock
50 mg In-stock
100 mg In-stock
200 mg   Get quote  
500 mg   Get quote  

* Please select Quantity before adding items.

This product is a controlled substance and not for sale in your territory.

Customer Review

Based on 31 publication(s) in Google Scholar

Other Forms of Serotonin:

Top Publications Citing Use of Products
Cell Proliferation/Viability Assay
ELISA
Cell Migration/Invasion Assay
RT-PCR
WB

    Serotonin purchased from MedChemExpress. Usage Cited in: iScience. 2025 Nov 19;28(12):114120.  [Abstract]

    Scratch tests were used to observe the migration ability of MLE-12 cells treated with 5-HT (Serotonin, 10 μM) for 24 h.

    Serotonin purchased from MedChemExpress. Usage Cited in: iScience. 2025 Jun 18;28(7):112931.  [Abstract]

    SH-SY5Y cells were treated with 10 μM Serotonin (5-HT), then the intracellular 5-HT was detected through ELISA assay for 0, 60, 120 min.

    Serotonin purchased from MedChemExpress. Usage Cited in: Curr Res Food Sci. 2024 Apr 26:8:100754.  [Abstract]

    Dose-response and time course of cell viability after in vitro administration of 5-HT(Serotonin);

    Serotonin purchased from MedChemExpress. Usage Cited in: J Immunother Cancer. 2021 Jul;9(7):e002383.  [Abstract]

    Relative IDO1 transcription levels detected by quantitative reverse transcription PCR (qRT-PCR) analysis in BT549 cells treated with dimethyl sulfoxide (DMSO), tetrahydrobiopterin (BH4, 10 µM), 5-HTP (500 µM), serotonin (10 µM), NAS (100 µM), and melatonin (1 µM) for 24 hours.

    Serotonin purchased from MedChemExpress. Usage Cited in: J Immunother Cancer. 2021 Jul;9(7):e002383.  [Abstract]

    Relative IDO1 levels detected by western blot in BT549 cells treated with dimethyl sulfoxide (DMSO), tetrahydrobiopterin (BH4, 10 µM), 5-HTP (500 µM), serotonin (10 µM), NAS (100 µM), and melatonin (1 µM) for 24 hours.
    • Biological Activity

    • Protocol

    • Purity & Documentation

    • References

    • Customer Review

    Description

    Serotonin is a monoamine neurotransmitter in the CNS and an endogenous 5-HT receptor agonist. Serotonin is also a catechol O-methyltransferase (COMT) inhibitor with a Ki of 44 μM.

    IC50 & Target

    Microbial Metabolite

     

    Human Endogenous Metabolite

     

    Cellular Effect
    Cell Line Type Value Description References
    B16 IC50
    550 μM
    Compound: 17
    Inhibition of catecholase activity of tyrosinase in mouse B16 cells assessed as dopachrome formation
    Inhibition of catecholase activity of tyrosinase in mouse B16 cells assessed as dopachrome formation
    [PMID: 19524439]
    B16 IC50
    > 30 μM
    Compound: 17
    Antimelanogenic activity in mouse B16 cells assessed as inhibition of intracellular melanin accumulation after 2 days
    Antimelanogenic activity in mouse B16 cells assessed as inhibition of intracellular melanin accumulation after 2 days
    [PMID: 19524439]
    C6 EC50
    12 nM
    Compound: 5-HT
    Agonist activity at human 5HT4 isoform E receptor expressed in rat C6 cells assessed as cAMP accumulation by radio-immunoassay relative to 5HT
    Agonist activity at human 5HT4 isoform E receptor expressed in rat C6 cells assessed as cAMP accumulation by radio-immunoassay relative to 5HT
    [PMID: 19334715]
    CHO EC50
    0.7 nM
    Compound: 5-HT
    Agonist activity assessed by stimulation of [35S]GTP-gamma-S binding to human 5HT1A receptor expressed in CHO cells
    Agonist activity assessed by stimulation of [35S]GTP-gamma-S binding to human 5HT1A receptor expressed in CHO cells
    [PMID: 16458504]
    CHO EC50
    1 nM
    Compound: 5-HT
    Agonistic activity at human 5HT1A in CHO cells by the inhibition of forskolin-stimulated cAMP accumulation
    Agonistic activity at human 5HT1A in CHO cells by the inhibition of forskolin-stimulated cAMP accumulation
    [PMID: 16392798]
    CHO EC50
    1.5 nM
    Compound: 2
    Binding to human 5HT2B receptor expressed in CHO cells
    Binding to human 5HT2B receptor expressed in CHO cells
    [PMID: 16257207]
    CHO EC50
    1.5 nM
    Compound: 5-HT
    Functional activity against human 5-hydroxytryptamine 2B receptor expressed in CHO cells using fluorometric imaging plate reader
    Functional activity against human 5-hydroxytryptamine 2B receptor expressed in CHO cells using fluorometric imaging plate reader
    [PMID: 15081042]
    CHO EC50
    1.63 nM
    Compound: 5-HT
    Agonist activity at 5HT2C receptor expressed in CHO cells by fluorescence based calcium mobilization assay
    Agonist activity at 5HT2C receptor expressed in CHO cells by fluorescence based calcium mobilization assay
    [PMID: 22381048]
    CHO EC50
    1.7 nM
    Compound: 2
    Binding to human 5HT2C receptor expressed in CHO cells
    Binding to human 5HT2C receptor expressed in CHO cells
    [PMID: 16257207]
    CHO EC50
    1.7 nM
    Compound: 5-HT
    Functional activity against human 5-hydroxytryptamine 2C receptor expressed in CHO cells using fluorometric imaging plate reader
    Functional activity against human 5-hydroxytryptamine 2C receptor expressed in CHO cells using fluorometric imaging plate reader
    [PMID: 15081042]
    CHO EC50
    11 nM
    Compound: 2
    Binding to human 5HT2A receptor expressed in CHO cells
    Binding to human 5HT2A receptor expressed in CHO cells
    [PMID: 16257207]
    CHO EC50
    11 nM
    Compound: 5-HT
    Functional activity against human 5-hydroxytryptamine 2A receptor expressed in CHO cells using fluorometric imaging plate reader
    Functional activity against human 5-hydroxytryptamine 2A receptor expressed in CHO cells using fluorometric imaging plate reader
    [PMID: 15081042]
    CHO EC50
    147 nM
    Compound: 5-HT
    Agonist activity at 5HT1A receptor expressed in CHO cells assessed as stimulation of [35S]GTPgamma binding
    Agonist activity at 5HT1A receptor expressed in CHO cells assessed as stimulation of [35S]GTPgamma binding
    [PMID: 20041669]
    CHO EC50
    150 nM
    Compound: 5-HT
    Agonist activity at 5HT1A receptor expressed in CHO cells by [35S]GTPgammaS binding assay
    Agonist activity at 5HT1A receptor expressed in CHO cells by [35S]GTPgammaS binding assay
    [PMID: 19559623]
    CHO EC50
    24 nM
    Compound: 5-HT
    Agonist activity at human cloned 5HT2C receptor expressed in CHO cells assessed as myo-[3H]inositol hydrolysis
    Agonist activity at human cloned 5HT2C receptor expressed in CHO cells assessed as myo-[3H]inositol hydrolysis
    [PMID: 18035544]
    CHO EC50
    25 nM
    Compound: 5-HT
    Agonist activity at human recombinant 5HT2C receptor expressed in CHO K1 cells assessed as induction of calcium mobilization by FLIPR assay
    Agonist activity at human recombinant 5HT2C receptor expressed in CHO K1 cells assessed as induction of calcium mobilization by FLIPR assay
    [PMID: 19646865]
    CHO EC50
    3.7 nM
    Compound: 5-HT
    Tested for functional response on CHO cells expressing cloned human 5-hydroxytryptamine 1A receptor
    Tested for functional response on CHO cells expressing cloned human 5-hydroxytryptamine 1A receptor
    [PMID: 12954071]
    CHO EC50
    4.67 nM
    Compound: 1
    The intrinsic activity was evaluated for its ability to inhibit forskolin-stimulated c-AMP formation mediated by cloned 5-hydroxytryptamine 1B receptor in CHO cell line; Full Agonist
    The intrinsic activity was evaluated for its ability to inhibit forskolin-stimulated c-AMP formation mediated by cloned 5-hydroxytryptamine 1B receptor in CHO cell line; Full Agonist
    [PMID: 9871775]
    CHO EC50
    70 nM
    Compound: 5-HT
    Agonist activity at human cloned 5HT2A receptor expressed in CHO cells assessed as myo-[3H]inositol hydrolysis
    Agonist activity at human cloned 5HT2A receptor expressed in CHO cells assessed as myo-[3H]inositol hydrolysis
    [PMID: 18035544]
    CHO IC50
    1.2 x 10-7 M
    Compound: Serotonin
    Displacement of [3H]LSD from human recombinant 5-HT6 receptor expressed in CHO cells
    Displacement of [3H]LSD from human recombinant 5-HT6 receptor expressed in CHO cells
    [PMID: 26988801]
    CHO IC50
    1.2 x 10-7 M
    Compound: Serotonin
    Displacement of [3H]LSD from human recombinant 5HT6 receptor expressed in CHO cells measured after 120 mins by scintillation counting method
    Displacement of [3H]LSD from human recombinant 5HT6 receptor expressed in CHO cells measured after 120 mins by scintillation counting method
    [PMID: 27876250]
    CHO IC50
    2.5 x 10-10 M
    Compound: Serotonin
    Displacement of [3H]LSD from human recombinant 5-HT7 receptor expressed in CHO cells
    Displacement of [3H]LSD from human recombinant 5-HT7 receptor expressed in CHO cells
    [PMID: 26988801]
    CHO IC50
    2.5 x 10-10 M
    Compound: Serotonin
    Displacement of [3H]LSD from human recombinant 5HT7 receptor expressed in CHO cells measured after 120 mins by scintillation counting method
    Displacement of [3H]LSD from human recombinant 5HT7 receptor expressed in CHO cells measured after 120 mins by scintillation counting method
    [PMID: 27876250]
    CHO IC50
    2.55 x 10-3 μM
    Compound: 5-HT
    Displacement of [3H]LSD from human 5HT7 receptor expressed in CHO cells
    Displacement of [3H]LSD from human 5HT7 receptor expressed in CHO cells
    [PMID: 12713409]
    CHO-K1 EC50
    0.07 μM
    Compound: Serotonin
    Agonist activity at human recombinant 5-HT7 receptor expressed in CHOK1 Hunter cell incubated for 30 to 60 mins by hit-hunter cAMP assay based chemiluminescence analysis
    Agonist activity at human recombinant 5-HT7 receptor expressed in CHOK1 Hunter cell incubated for 30 to 60 mins by hit-hunter cAMP assay based chemiluminescence analysis
    [PMID: 32631561]
    CHO-K1 EC50
    15 nM
    Compound: Serotonin
    Agonist activity at human recombinant 5HT7 receptor expressed in CHOK1 cells assessed as increase in cAMP levels by HTRF assay
    Agonist activity at human recombinant 5HT7 receptor expressed in CHOK1 cells assessed as increase in cAMP levels by HTRF assay
    [PMID: 19326916]
    CHO-K1 EC50
    15.33 nM
    Compound: 5-HT
    Agonist activity at 5-HT1A receptor (unknown origin) expressed in CHOK1 cells co-expressing G-alpha 15 by Fluo-4 dye based FLIPR assay
    Agonist activity at 5-HT1A receptor (unknown origin) expressed in CHOK1 cells co-expressing G-alpha 15 by Fluo-4 dye based FLIPR assay
    [PMID: 27487565]
    CHO-K1 EC50
    16 nM
    Compound: 5-HT
    Agonist activity at 5HT2A receptor (unknown origin) expressed in CHOK1 cells coexpressing Galpha15 by FLIPR assay
    Agonist activity at 5HT2A receptor (unknown origin) expressed in CHOK1 cells coexpressing Galpha15 by FLIPR assay
    [PMID: 23675993]
    CHO-K1 EC50
    18 nM
    Compound: Serotonin
    Agonist activity at human recombinant 5HT1A receptor (unknown origin) stably expressed in CHO-K1 incubated for 30 mins by [35S]GTPgammaS binding assay
    Agonist activity at human recombinant 5HT1A receptor (unknown origin) stably expressed in CHO-K1 incubated for 30 mins by [35S]GTPgammaS binding assay
    [PMID: 31627993]
    CHO-K1 EC50
    39 nM
    Compound: 5-HT
    Agonist activity at 5HT1A receptor (unknown origin) expressed in CHOK1 cells coexpressing Galpha15 by FLIPR assay
    Agonist activity at 5HT1A receptor (unknown origin) expressed in CHOK1 cells coexpressing Galpha15 by FLIPR assay
    [PMID: 23675993]
    CHO-K1 EC50
    4.82 nM
    Compound: 5-HT
    Inhibition of forskolin-stimulated c-AMP formation by human 5-hydroxytryptamine 1B receptor expressed in CHO-K1 cells
    Inhibition of forskolin-stimulated c-AMP formation by human 5-hydroxytryptamine 1B receptor expressed in CHO-K1 cells
    [PMID: 8960551]
    CHO-K1 EC50
    45.3 nM
    Compound: Serotonin
    Partial agonist activity at recombinant human 5-HT1A expressed in CHO-K1 cells by pathhunter beta-arrestin assay
    Partial agonist activity at recombinant human 5-HT1A expressed in CHO-K1 cells by pathhunter beta-arrestin assay
    [PMID: 32631554]
    CHO-K1 EC50
    47 nM
    Compound: 5-HT
    Agonist activity at 5-HT2A receptor (unknown origin) expressed in CHOK1 cells co-expressing G-alpha 15 by Fluo-4 dye based FLIPR assay
    Agonist activity at 5-HT2A receptor (unknown origin) expressed in CHOK1 cells co-expressing G-alpha 15 by Fluo-4 dye based FLIPR assay
    [PMID: 27487565]
    Flp-In-293 EC50
    0.19 nM
    Compound: Serotonin
    Agonist activity at recombinant human unedited 5HT2C receptor isoform INI expressed in Flp-In-293 cells assessed as increase in calcium influx measured for 300 secs by Fluo-4 dye based FLIPR assay
    Agonist activity at recombinant human unedited 5HT2C receptor isoform INI expressed in Flp-In-293 cells assessed as increase in calcium influx measured for 300 secs by Fluo-4 dye based FLIPR assay
    [PMID: 31445232]
    Flp-In-293 EC50
    0.27 nM
    Compound: Serotonin
    Agonist activity at recombinant human 5HT2A receptor expressed in Flp-In-293 cells assessed as increase in calcium influx measured for 300 secs by Fluo-4 dye based FLIPR assay
    Agonist activity at recombinant human 5HT2A receptor expressed in Flp-In-293 cells assessed as increase in calcium influx measured for 300 secs by Fluo-4 dye based FLIPR assay
    [PMID: 31445232]
    Flp-In-293 EC50
    0.86 nM
    Compound: Serotonin
    Agonist activity at recombinant human 5HT2B receptor expressed in Flp-In-293 cells assessed as increase in calcium influx measured for 300 secs by Fluo-4 dye based FLIPR assay
    Agonist activity at recombinant human 5HT2B receptor expressed in Flp-In-293 cells assessed as increase in calcium influx measured for 300 secs by Fluo-4 dye based FLIPR assay
    [PMID: 31445232]
    HEK293 EC50
    0.00087 μM
    Compound: 5-HT, serotonin
    Agonist activity at human 5HT2C receptor expressed in HEK293 cells assessed as induction of intracellular calcium release measured for 90 secs by fluorescence assay
    Agonist activity at human 5HT2C receptor expressed in HEK293 cells assessed as induction of intracellular calcium release measured for 90 secs by fluorescence assay
    [PMID: 23301527]
    HEK293 EC50
    0.0026 μM
    Compound: 5-HT, serotonin
    Agonist activity at human 5HT2A receptor expressed in HEK293 cells assessed as induction of intracellular calcium release measured for 90 secs by fluorescence assay
    Agonist activity at human 5HT2A receptor expressed in HEK293 cells assessed as induction of intracellular calcium release measured for 90 secs by fluorescence assay
    [PMID: 23301527]
    HEK293 EC50
    0.017 μM
    Compound: 5-HT, serotonin
    Agonist activity at human 5-HT7 expressed in HEK-293 cells assessed as increase in cAMP level after 45 mins by HTRF assay
    Agonist activity at human 5-HT7 expressed in HEK-293 cells assessed as increase in cAMP level after 45 mins by HTRF assay
    [PMID: 25073094]
    HEK293 EC50
    0.044 μM
    Compound: 5-HT, serotonin
    Agonist activity at human 5HT2C receptor expressed in HEK293 cells assessed as accumulation of IP1 incubated for 1 hr at 37 degC followed by 15 mins at RT by TR-FRET assay
    Agonist activity at human 5HT2C receptor expressed in HEK293 cells assessed as accumulation of IP1 incubated for 1 hr at 37 degC followed by 15 mins at RT by TR-FRET assay
    [PMID: 23301527]
    HEK293 EC50
    0.09 nM
    Compound: 1
    Agonist activity at human 5HT2C receptor expressed in HEK293 cells assessed as calcium flux by FLIPR assay
    Agonist activity at human 5HT2C receptor expressed in HEK293 cells assessed as calcium flux by FLIPR assay
    [PMID: 19284718]
    HEK293 EC50
    0.09 nM
    Compound: 5-HT
    Agonist activity at human 5HT2C receptor expressed in HEK293 cells assessed as calcium flux measured every sec for 3 mins by FLIPR assay
    Agonist activity at human 5HT2C receptor expressed in HEK293 cells assessed as calcium flux measured every sec for 3 mins by FLIPR assay
    [PMID: 22778800]
    HEK293 EC50
    0.1 μM
    Compound: serotonin
    Activity at SER4 receptor expressed in HEK293 cells assessed as increase in calcium by calcium imaging assay
    Activity at SER4 receptor expressed in HEK293 cells assessed as increase in calcium by calcium imaging assay
    [PMID: 18033297]
    HEK293 EC50
    0.15 μM
    Compound: 5-HT, serotonin
    Agonist activity at human 5HT2A receptor expressed in HEK293 cells assessed as accumulation of IP1 incubated for 1 hr at 37 degC followed by 15 mins at RT by TR-FRET assay
    Agonist activity at human 5HT2A receptor expressed in HEK293 cells assessed as accumulation of IP1 incubated for 1 hr at 37 degC followed by 15 mins at RT by TR-FRET assay
    [PMID: 23301527]
    HEK293 EC50
    0.17 nM
    Compound: 5-HT
    Agonist activity at human 5-HT2C-INI receptor isoform expressed in Flp-IN HEK293 cells assessed as induction of Gq-mediated calcium flux measured every second for 5 mins by Fluo-4 dye based FLIPR assay
    Agonist activity at human 5-HT2C-INI receptor isoform expressed in Flp-IN HEK293 cells assessed as induction of Gq-mediated calcium flux measured every second for 5 mins by Fluo-4 dye based FLIPR assay
    [PMID: 28657744]
    HEK293 EC50
    0.21 nM
    Compound: 5-HT
    Agonist activity at human 5-HT2C receptor expressed in HEK293 cells assessed as calcium flux by FLIPR assay
    Agonist activity at human 5-HT2C receptor expressed in HEK293 cells assessed as calcium flux by FLIPR assay
    [PMID: 25633969]
    HEK293 EC50
    0.4 nM
    Compound: 5-HT
    Agonist activity at human 5-HT2C receptor expressed in HEK293 cells assessed as increase in calcium mobilization by FLIPR assay
    Agonist activity at human 5-HT2C receptor expressed in HEK293 cells assessed as increase in calcium mobilization by FLIPR assay
    [PMID: 23602445]
    HEK293 EC50
    0.41 nM
    Compound: 5-HT
    Agonist activity at human 5HT2C receptor stably expressed in HEK293 cells co-expressing Gq assessed as induction of calcium mobilization measured at 1 sec interval for 60 secs by Fluo-4 calcium dye based FLIPR assay
    Agonist activity at human 5HT2C receptor stably expressed in HEK293 cells co-expressing Gq assessed as induction of calcium mobilization measured at 1 sec interval for 60 secs by Fluo-4 calcium dye based FLIPR assay
    [PMID: 32282200]
    HEK293 EC50
    0.5 nM
    Compound: 1
    Agonist activity at human 5HT2B receptor expressed in HEK293 cells assessed as calcium flux by FLIPR assay
    Agonist activity at human 5HT2B receptor expressed in HEK293 cells assessed as calcium flux by FLIPR assay
    [PMID: 19284718]
    HEK293 EC50
    0.5 μM
    Compound: 5-HT
    Antagonist activity at human 5HT3A receptor expressed in HEK293 cells by FMP assay
    Antagonist activity at human 5HT3A receptor expressed in HEK293 cells by FMP assay
    [PMID: 17722904]
    HEK293 EC50
    0.86 nM
    Compound: 5-HT
    Agonist activity at human 5HT2B receptor expressed in HEK293 cells assessed as calcium flux measured every sec for 3 mins by FLIPR assay
    Agonist activity at human 5HT2B receptor expressed in HEK293 cells assessed as calcium flux measured every sec for 3 mins by FLIPR assay
    [PMID: 22778800]
    HEK293 EC50
    0.92 nM
    Compound: 5-HT
    Agonist activity at human 5-HT2B receptor expressed in HEK293 cells assessed as calcium flux by FLIPR assay
    Agonist activity at human 5-HT2B receptor expressed in HEK293 cells assessed as calcium flux by FLIPR assay
    [PMID: 25633969]
    HEK293 EC50
    1.1 nM
    Compound: 5-HT
    Agonist activity at human 5-HT2B receptor expressed in HEK293 cells assessed as increase in calcium mobilization by FLIPR assay
    Agonist activity at human 5-HT2B receptor expressed in HEK293 cells assessed as increase in calcium mobilization by FLIPR assay
    [PMID: 23602445]
    HEK293 EC50
    1.46 nM
    Compound: 5-HT
    Agonist activity at human 5-HT2B receptor expressed in Flp-IN HEK293 cells assessed as induction of calcium flux measured every second for 5 mins by Fluo-4 dye based FLIPR assay
    Agonist activity at human 5-HT2B receptor expressed in Flp-IN HEK293 cells assessed as induction of calcium flux measured every second for 5 mins by Fluo-4 dye based FLIPR assay
    [PMID: 28657744]
    HEK293 EC50
    1.5 nM
    Compound: 5-HT
    Agonist activity at human 5-HT2A receptor expressed in HEK293 cells assessed as increase in calcium mobilization by FLIPR assay
    Agonist activity at human 5-HT2A receptor expressed in HEK293 cells assessed as increase in calcium mobilization by FLIPR assay
    [PMID: 23602445]
    HEK293 EC50
    1.88 nM
    Compound: 5-HT
    Agonist activity at human 5-HT2A receptor expressed in HEK293 cells assessed as calcium flux by FLIPR assay
    Agonist activity at human 5-HT2A receptor expressed in HEK293 cells assessed as calcium flux by FLIPR assay
    [PMID: 25633969]
    HEK293 EC50
    141 nM
    Compound: 5-HT
    Partial agonist activity at human 5HT3A receptor expressed in HEK293 cells assessed as decrease in 10 uM 5-chloroindole-induced increase in intracellular calcium release
    Partial agonist activity at human 5HT3A receptor expressed in HEK293 cells assessed as decrease in 10 uM 5-chloroindole-induced increase in intracellular calcium release
    [PMID: 21146988]
    HEK293 EC50
    178 nM
    Compound: 5-HT
    Partial agonist activity at human 5HT3A receptor expressed in HEK293 cells assessed as effect on serotonin-induced response
    Partial agonist activity at human 5HT3A receptor expressed in HEK293 cells assessed as effect on serotonin-induced response
    [PMID: 21146988]
    HEK293 EC50
    2.35 nM
    Compound: 5-HT
    Agonist activity at human 5-HT2A receptor expressed in Flp-IN HEK293 cells assessed as induction of calcium flux measured every second for 5 mins by Fluo-4 dye based FLIPR assay
    Agonist activity at human 5-HT2A receptor expressed in Flp-IN HEK293 cells assessed as induction of calcium flux measured every second for 5 mins by Fluo-4 dye based FLIPR assay
    [PMID: 28657744]
    HEK293 EC50
    3.75 nM
    Compound: 5-HT
    Agonist activity at 5-HT1A receptor (unknown origin) expressed in HEK293 cells assessed as inhibition of [35S]GTPgammaS binding by scintillation proximity assay
    Agonist activity at 5-HT1A receptor (unknown origin) expressed in HEK293 cells assessed as inhibition of [35S]GTPgammaS binding by scintillation proximity assay
    [PMID: 23332346]
    HEK293 EC50
    5.8 nM
    Compound: 1
    Agonist activity at human 5HT2A receptor expressed in HEK293 cells assessed as calcium flux by FLIPR assay
    Agonist activity at human 5HT2A receptor expressed in HEK293 cells assessed as calcium flux by FLIPR assay
    [PMID: 19284718]
    HEK293 EC50
    5.8 x 10-3 μM
    Compound: 5-HT
    Agonist activity at human 5-HT7R expressed in HEK293 cells assessed as induction of cAMP levels treated for 10 mins measured after 30 mins by D2-dye based fluorescence assay
    Agonist activity at human 5-HT7R expressed in HEK293 cells assessed as induction of cAMP levels treated for 10 mins measured after 30 mins by D2-dye based fluorescence assay
    [PMID: 27475109]
    HEK293 EC50
    7.6 nM
    Compound: 5-HT
    Agonist activity at human 5HT2A receptor expressed in HEK293 cells assessed as calcium flux measured every sec for 3 mins by FLIPR assay
    Agonist activity at human 5HT2A receptor expressed in HEK293 cells assessed as calcium flux measured every sec for 3 mins by FLIPR assay
    [PMID: 22778800]
    HEK293 IC50
    1.8 x 10-7 M
    Compound: Serotonin
    Displacement of [3H]LSD from human recombinant 5-HT5A receptor expressed in HEK293 cells
    Displacement of [3H]LSD from human recombinant 5-HT5A receptor expressed in HEK293 cells
    [PMID: 26988801]
    HEK293 IC50
    1.8 x 10-7 M
    Compound: Serotonin
    Displacement of [3H]LSD from human recombinant 5HT5A receptor expressed in HEK293 cells measured after 120 mins by scintillation counting method
    Displacement of [3H]LSD from human recombinant 5HT5A receptor expressed in HEK293 cells measured after 120 mins by scintillation counting method
    [PMID: 27876250]
    HEK293 IC50
    260 nM
    Compound: Serotonin
    Displacement of [3H]LSD from human recombinant 5-HT5a receptor in HEK293 cells after 120 mins by scintillation counting
    Displacement of [3H]LSD from human recombinant 5-HT5a receptor in HEK293 cells after 120 mins by scintillation counting
    [PMID: 27997171]
    HEK293-EBNA EC50
    5.8 nM
    Compound: 5-HT
    Agonist activity at human cloned 5HT2B receptor expressed in HEK293-EBNA cells assessed as myo-[3H]inositol hydrolysis
    Agonist activity at human cloned 5HT2B receptor expressed in HEK293-EBNA cells assessed as myo-[3H]inositol hydrolysis
    [PMID: 18035544]
    HRPE IC50
    97 μM
    Compound: Serotonin
    TP_TRANSPORTER: inhibition of MPP+ uptake (MPP+: 1 uM) in OCT3-expressing HRPE cells
    TP_TRANSPORTER: inhibition of MPP+ uptake (MPP+: 1 uM) in OCT3-expressing HRPE cells
    [PMID: 9830022]
    NG108-15 EC50
    293 nM
    Compound: 5-HT
    In Vitro 5-HT3 agonist activity on the [14C]guanidinium accumulation in NG 108-15 cells.
    In Vitro 5-HT3 agonist activity on the [14C]guanidinium accumulation in NG 108-15 cells.
    [PMID: 9191957]
    NG108-15 EC50
    298 nM
    Compound: 5-HT
    Quantitative effect on the [14C]guanidinium accumulation in NG 108-15 cells.
    Quantitative effect on the [14C]guanidinium accumulation in NG 108-15 cells.
    [PMID: 10229626]
    Oocyte EC50
    12 μM
    Compound: Serotonin
    Response at rat 5-hydroxytryptamine 3a receptor expressed in xenopus oocytes
    Response at rat 5-hydroxytryptamine 3a receptor expressed in xenopus oocytes
    [PMID: 15050614]
    U2OS IC50
    1.25 nM
    Compound: Serotonin
    Antagonist activity at recombinant human 5-HT2C expressed in human U2OS cells by pathhunter beta-arrestin assay
    Antagonist activity at recombinant human 5-HT2C expressed in human U2OS cells by pathhunter beta-arrestin assay
    [PMID: 32631554]
    U2OS IC50
    27.9 nM
    Compound: Serotonin
    Antagonist activity at recombinant human 5-HT2A expressed in human U2OS cells by pathhunter beta-arrestin assay
    Antagonist activity at recombinant human 5-HT2A expressed in human U2OS cells by pathhunter beta-arrestin assay
    [PMID: 32631554]
    In Vitro

    Serotonin is a monoamine neurotransmitter in the CNS and an endogenous 5-HT receptor agonist. Serotonin also inhibits catechol O-methyltransferase (COMT), an enzyme that contributes to modultion the perception of pain, via non-competitive binding to the site bound by catechol substrates with a binding affinity comparable to the binding affinity of catechol itself (Ki= 44 μM). Results show that addition of 100 μM of Serotonin decreases the reaction velocity of COMT[1].

    MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

    In Vivo

    Serotonin produces robust hypersensitivity compare to saline-treated controls (p<0.001)[1].

    MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

    Molecular Weight

    176.22

    Formula

    C10H12N2O

    CAS No.
    Appearance

    Solid

    Color

    Light yellow to brown

    SMILES

    OC1=CC2=C(NC=C2CCN)C=C1

    Structure Classification
    Initial Source
    Shipping

    Room temperature in continental US; may vary elsewhere.

    Storage

    -20°C, sealed storage, away from moisture

    *In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)

    Solvent & Solubility
    In Vitro: 

    DMSO : 100 mg/mL (567.47 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)

    Preparing
    Stock Solutions
    Concentration Solvent Mass 1 mg 5 mg 10 mg
    1 mM 5.6747 mL 28.3736 mL 56.7472 mL
    5 mM 1.1349 mL 5.6747 mL 11.3494 mL
    View the Complete Stock Solution Preparation Table

    * Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
    Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.

    • Molarity Calculator

    • Dilution Calculator

    Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

    Mass
    =
    Concentration
    ×
    Volume
    ×
    Molecular Weight *

    Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

    This equation is commonly abbreviated as: C1V1 = C2V2

    Concentration (start)

    C1

    ×
    Volume (start)

    V1

    =
    Concentration (final)

    C2

    ×
    Volume (final)

    V2

    In Vivo:

    Select the appropriate dissolution method based on your experimental animal and administration route.

    For the following dissolution methods, please ensure to first prepare a clear stock solution using an In Vitro approach and then sequentially add co-solvents:
    To ensure reliable experimental results, the clarified stock solution can be appropriately stored based on storage conditions. As for the working solution for in vivo experiments, it is recommended to prepare freshly and use it on the same day.
    The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.

    • Protocol 1

      Add each solvent one by one:  10% DMSO    40% PEG300    5% Tween-80    45% Saline

      Solubility: ≥ 2.5 mg/mL (14.19 mM); Clear solution

      This protocol yields a clear solution of ≥ 2.5 mg/mL (saturation unknown).

      Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (25.0 mg/mL) to 400 μL PEG300, and mix evenly; then add 50 μL Tween-80 and mix evenly; then add 450 μL Saline to adjust the volume to 1 mL.

      Preparation of Saline: Dissolve 0.9 g sodium chloride in ddH₂O and dilute to 100 mL to obtain a clear Saline solution.
    • Protocol 2

      Add each solvent one by one:  10% DMSO    90% (20% SBE-β-CD in Saline)

      Solubility: ≥ 2.5 mg/mL (14.19 mM); Clear solution

      This protocol yields a clear solution of ≥ 2.5 mg/mL (saturation unknown).

      Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (25.0 mg/mL) to 900 μL 20% SBE-β-CD in Saline, and mix evenly.

      Preparation of 20% SBE-β-CD in Saline (4°C, storage for one week): 2 g SBE-β-CD powder is dissolved in 10 mL Saline, completely dissolve until clear.
    In Vivo Dissolution Calculator
    Please enter the basic information of animal experiments:

    Dosage

    mg/kg

    Animal weight
    (per animal)

    g

    Dosing volume
    (per animal)

    μL

    Number of animals

    Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.
    Please enter your animal formula composition:
    %
    DMSO +
    +
    %
    Tween-80 +
    %
    Saline
    Recommended: Keep the proportion of DMSO in working solution below 2% if your animal is weak.
    The co-solvents required include: DMSO, . All of co-solvents are available by MedChemExpress (MCE). , Tween 80. All of co-solvents are available by MedChemExpress (MCE).
    Calculation results:
    Working solution concentration: mg/mL
    Method for preparing stock solution: mg drug dissolved in μL  DMSO (Stock solution concentration: mg/mL).

    *In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)

    The concentration of the stock solution you require exceeds the measured solubility. The following solution is for reference only. If necessary, please contact MedChemExpress (MCE).
    Method for preparing in vivo working solution for animal experiments: Take μL DMSO stock solution, add μL . μL , mix evenly, next add μL Tween 80, mix evenly, then add μL Saline.
     If the continuous dosing period exceeds half a month, please choose this protocol carefully.
    Please ensure that the stock solution in the first step is dissolved to a clear state, and add co-solvents in sequence. You can use ultrasonic heating (ultrasonic cleaner, recommended frequency 20-40 kHz), vortexing, etc. to assist dissolution.
    Purity & Documentation

    Purity: 99.86%

    References
    Cell Assay
    [2]

    For macrophage culture, peritoneal cavity cells are collected from WT and IL-13-/- mice with or without dextran sodium sulfate (DSS) treatment and cultured. Cells are plated at a concentration of 3.0×106 cells per millilitre, and treated with either lipopolysaccharides (LPS); (100 ng/mL) or Serotonin (10-10 M) for 24 hours. The culture supernatant are collected and stored in -80°C until determination of cytokine levels using protein array system[2].

    MCE has not independently confirmed the accuracy of these methods. They are for reference only.

    Animal Administration
    [2]

    Dextran sodium sulfate (DSS) colitis is induced by orally administering 5% DSS in drinking water for 5 days. In a separate experiment, IL-13-/- mice are injected subcutaneously with 100 mg/kg of Serotonin (5-HTP) twice daily for 8 days beginning 3 days prior to induction of DSS colitis; whereas, the control IL-13-/- mice receive saline as vehicle. Animals are anaesthetized prior to euthanization via cervical dislocation at the conclusion of each experiment or if they reach a predetermined end point (ie, loss of ≥20% body weight and/or significant deterioration of body condition)[2].

    MCE has not independently confirmed the accuracy of these methods. They are for reference only.

    References

    Complete Stock Solution Preparation Table

    * Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
    Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.

    Optional Solvent Concentration Solvent Mass 1 mg 5 mg 10 mg 25 mg
    DMSO 1 mM 5.6747 mL 28.3736 mL 56.7472 mL 141.8681 mL
    5 mM 1.1349 mL 5.6747 mL 11.3494 mL 28.3736 mL
    10 mM 0.5675 mL 2.8374 mL 5.6747 mL 14.1868 mL
    15 mM 0.3783 mL 1.8916 mL 3.7831 mL 9.4579 mL
    20 mM 0.2837 mL 1.4187 mL 2.8374 mL 7.0934 mL
    25 mM 0.2270 mL 1.1349 mL 2.2699 mL 5.6747 mL
    30 mM 0.1892 mL 0.9458 mL 1.8916 mL 4.7289 mL
    40 mM 0.1419 mL 0.7093 mL 1.4187 mL 3.5467 mL
    50 mM 0.1135 mL 0.5675 mL 1.1349 mL 2.8374 mL
    60 mM 0.0946 mL 0.4729 mL 0.9458 mL 2.3645 mL
    80 mM 0.0709 mL 0.3547 mL 0.7093 mL 1.7734 mL
    100 mM 0.0567 mL 0.2837 mL 0.5675 mL 1.4187 mL
    • No file chosen (Maximum size is: 1024 Kb)
    • If you have published this work, please enter the PubMed ID.
    • Your name will appear on the site.
    Help & FAQs
    • Do most proteins show cross-species activity?

      Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

    Your Recently Viewed Products:

    Inquiry Online

    Your information is safe with us. * Required Fields.

    Product Name

     

    Requested Quantity *

    Applicant Name *

     

    Salutation

    Email Address *

     

    Phone Number *

    Department

     

    Organization Name *

    City

    State

    Country or Region *

         

    Remarks

    Bulk Inquiry

    Inquiry Information

    Product Name:
    Serotonin
    Cat. No.:
    HY-B1473A
    Quantity:
    MCE Japan Authorized Agent: